1
A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers
Condition(s):Chronic Hepatitis CLast Updated:October 16, 2019Completed
Simeprevir: 117 Clinical Trials, Page 1 of 12
Hide Studies Not Open or Pending
2
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection
Condition(s):Chronic Hepatitis C; Genotype 4 Chronic Hepatitis CLast Updated:November 17, 2016Completed
3
A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
Condition(s):Hepatitis C, Chronic; HIV CDC Category A1Last Updated:June 13, 2019Withdrawn
4
A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants
Condition(s):Hepatitis C, ChronicLast Updated:March 16, 2017Completed
5
A Study to Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male Patients
Condition(s):Healthy Male ParticipantsLast Updated:March 28, 2014Completed
6
Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients
Condition(s):Liver CirrhosisLast Updated:March 9, 2016Completed
7
Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)
Condition(s):Hepatitis C, ChronicLast Updated:August 1, 2017Completed
8
Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection
Condition(s):Chronic Hepatitis CLast Updated:February 24, 2016Completed
9
Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers
Condition(s):HIV; Hepatitis CLast Updated:November 14, 2017Completed
10
An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease
Condition(s):Hepatitis C, ChronicLast Updated:May 8, 2019Completed